Paper Details

  1. Home
  2. Paper Details

Fractional Exhalation Nitric Oxide (FeNO) changes in cystic fibrosis patients induced by compound honey syrup: a pretest-posttest clinical trial.

Author: ChoopaniRasool, DerikvandiShima, FadaviNafise, KavehShahpar, KhanbabaeeGhamartaj, RouzbahaniArian Karimi, SadrSaeed, TabatabaeiSeyed Ahmad, TahermohammadiHanieh

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

A before-after clinical trial of 44 patients with cystic fibrosis (CF) found that compound honey syrup (CHS) was effective in reducing fractional exhalation nitric oxide (FeNO) levels, a marker of airway inflammation, and was well-tolerated.
Paper Details　
Original Abstract of the Article :
OBJECTIVE: To evaluate the effect of Persian medicine Syrup 'compound honey syrup (CHS)' on fractional exhalation nitric oxide (FENO) changes in patients with cystic fibrosis (CF). STUDY DESIGN: We conducted a before-after clinical trial on 70 CF patients. All patients received classical treatments...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696786/

データ提供：米国国立医学図書館（NLM）

Exploring Complementary Therapies for Cystic Fibrosis: A New Oasis in the Desert of Treatment Options

Cystic fibrosis (CF) is a complex and challenging condition, often requiring a multi-faceted approach to treatment. This study explores the potential of a Persian medicine syrup, 'compound honey syrup (CHS)', as a complementary therapy for CF patients. The researchers conducted a before-after clinical trial to evaluate the effects of CHS on fractional exhalation nitric oxide (FeNO) levels in CF patients. The findings suggest that CHS may offer a promising complementary therapy for CF, potentially improving lung function and reducing inflammation.

Compound Honey Syrup: A Potential Oasis in the Desert of CF Treatment

The study found that CHS significantly reduced FeNO levels in CF patients, suggesting that it may have beneficial effects on lung function and inflammation. This discovery offers a new avenue for exploring complementary therapies that could improve the quality of life for CF patients.

Navigating the Desert of CF Treatment

This study reminds us that the desert of CF treatment is vast and complex, requiring a multi-pronged approach to manage this challenging condition. Exploring complementary therapies like CHS could provide additional tools for improving patient outcomes and enhancing their quality of life.

Dr.Camel's Conclusion

This study offers a glimpse into the potential of complementary therapies for CF. The findings suggest that CHS could be a valuable addition to the existing treatment options, providing a more holistic approach to managing this complex condition.

Date :
  1. Date Completed 2023-12-07
  2. Date Revised 2023-12-08
Further Info :

Pubmed ID

38053097

DOI: Digital Object Identifier

PMC10696786

Related Literature

Article Analysis
・Side Effects of cinnamon
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.